Investigation Report on China Nicergoline Market, 2010-2019

May, 2015   |   30  Pages   |   China Research and Intelligence   |   Format : PDF

Description

Nicergoline is a kind of ergot alkaloid, which can dilatate the blood vessel of brain and improve the blood supply of brain. It can block α-receptor and accelerate metabolism as well as reduce the resistance of the blood vessel of brain and increase the blood flow of brain and the usage of glucose to improve mental retardation. Nicergoline can also accelerate the metabolism of dopamine, enhance the nerve conduction, improve the mental and emotional abnormality, accelerate the synthesis of the protein in brain, effectively improve memory, recover the normal function of nerve cells, entirely improve the clinic symptom of chronic brain dysfunction syndrome.

Nicergoline is first researched and produced by Pfizer Co., Ltd., which is widely used for many indications. It spreads to the globe after launching to the market.

Market size of nicergoline and its share in anti-Alzheimer's disease drug market is small as a drug used for 30 years. There are many substitutes and its product lifecycle is in recession. According to CRI's market research, the market size of nicergoline in sample hospitals was about CNY 89 million in 2010 and CNY 76 million in 2014.

In future years, China's nicergoline market will shrank because of the competition of other types of anti-AD drugs like biopharmaceuticals. However, the low-end market demand for nicergoline still exists, the nicergoline drug m

1 Relevant Concepts of Nicergoline
1.1 Introduction
1.2 Indication
1.3 Sales Status on the Global Market

2 Market Overview of Nicergoline in China
2.1 Patent Status
2.2 Major Nicergoline Manufacturers in China
2.3 Market Size

3 Investigation on Sales Value of Nicergoline in China, 2010-2014
3.1 Sales Value
3.1.1 Overview
3.1.2 Sales Value by Region
3.2 Sales Volume
3.2.1 Overview
3.2.2 Sales Volume by Region

4 Investigation on Market Share of Major Nicergoline Manufacturers in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Investigation on of Nicergoline by Dosage Form in China, 2010-2014
5.1 Market Share by Sales Value and Dosage Form
5.2 Market Share by Sales Volume and Dosage Form

6 Reference Price of Nicergoline in Hospital Market in China, 2014
6.1 PHARMACIA & UPJOHN S.p.A.
6.2 Kunshan Rotam Reddy Pharmaceutical Co., Ltd. (KRRP)
6.3 Hainan General Sanyang Pharmaceutical Co., Ltd.
6.4 Hainan Jinxiao Pharmaceutical Co., Ltd.
6.5 Pfizer Co., Ltd. (USA)
6.6 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd.

7 Major Manufacturers in China Nicergoline Market, 2010-2014
7.1 Kunshan Rotam Reddy Pharmaceutical Co., Ltd.
7.2 PHARMACIA & UPJOHN S.p.A.
7.3 Hainan General Sanyang Pharmaceutical Co., Ltd.
7.4 Hainan Jinxiao Pharmaceutical Co., Ltd.
7.5 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd.

8 Prospect of China Nicergoline Market, 2015-2019
8.1 Forecast on Market Size
8.2 Forecast on Competition Pattern

Selected Charts
Chart Approval Number of Nicergoline Made in China
Chart Market Size of Nicergoline in China, 2010-2014
Chart Sales Revenue of Nicergoline in China, 2010-2014
Chart Sales Revenue of Nicergoline by Region in China, 2010-2014
Chart Sales Volume of Nicergoline in China, 2010-2014
Chart Sales Volume of Nicergoline by Region in China, 2010-2014
Chart Sales Revenue of Nicergoline of Dalian Pfizer and Its Market Share, 2010-2014
Chart Sales Revenue of Nicergoline of Kunshan Rotam Reddy Pharmaceutical Co., Ltd. and Its Market Share, 2010-2014
Chart Sales Revenue of Nicergoline of PHARMACIA & UPJOHN S.p.A. and Its Market Share, 2010-2014
Chart Sales Revenue of Nicergoline of Hainan General Sanyang Pharmaceutical Co., Ltd. and Its Market Share, 2010-2014
Chart Sales Revenue of Nicergoline of Hainan Jinxiao Pharmaceutical Co., Ltd. and Its Market Share, 2010-2014
Chart Sales Revenue of Nicergoline of Ethypharm (French) and Its Market Share, 2010-2014
Chart Sales Revenue of Nicergoline of Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. and Its Market Share, 2010-2014
Chart Sales Revenue of Nicergoline of Chongqing Lummy Pharmaceutical Co., Ltd. and Its Market Share, 2010-2014
Chart Sales Volume of Nicergoline of Dalian Pfizer and Its Market Share, 2010-2014
Chart Sales Volume of Nicergoline of Kunshan Rotam Reddy Pharmaceutical Co., Ltd. and Its Market Share, 2010-2014
Chart Sales Volume of Nicergoline of PHARMACIA & UPJOHN S.p.A. and Its Market Share, 2010-2014
Chart Sales Volume of Nicergoline of Hainan General Sanyang Pharmaceutical Co., Ltd. and Its Market Share, 2010-2014
Chart Sales Volume of Nicergoline of Hainan Jinxiao Pharmaceutical Co., Ltd. and Its Market Share, 2010 -2014
Chart Sales Volume of Nicergoline of Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. and Its Market Share, 2010-2014
Chart Sales Volume of Nicergoline of Shandong Linzi Pharmaceutical Factory and Its Market Share, 2010-2014
Chart Sales Value and Market Share of Nicergoline Tablets in China, 2010-2014
Chart Sales Value and Market Share of Nicergoline Capsule Preparation in China, 2010-2014
Chart Sales Volume and Market Share of Nicergoline Tablets in China, 2010-2014
Chart Sales Volume and Market Share of Nicergoline Capsule Preparation in China, 2010-2014
Chart Price of Nicergoline Pr PHARMACIA & UPJOHN S.p.A. in China, 2014
Chart Price of Nicergoline Pr Kunshan Rotam Reddy Pharmaceutical Co., Ltd. in China, 2014
Chart Market Size Forecast of Nicergoline in China, 2015-2019

Investigation Report on China Valsartan Market, 2009-2018
Valsartan (Angiotan or Diovan) is an angiotensin II receptor antagonist (more commonly called an ARB, or angiotensin receptor blocker), with particularly high affinity for the type I (AT1) angiotensin receptor. In December 1996, Valsartan was approved by FDA. In the US, UK and Australia, valsa
Investigation Report on China Trastuzumab Market, 2010-2019
Monoclonal antibody, an epochal drug variety, plays an important role in the upgrading process of treatments for tumor and autoimmune disease, and has become a mainstream in the global market of targeting therapeutic agents. The manufacturers of antibody mainly concentrate in the hands of such
Investigation Report on China Atorvastatin Market, 2010-2019
With the change of life styles brought about by the economic development and the rising incomes, the number of hyperlipidemia patients in China keeps growing, being estimated to reach 160-200 million in the near future. Atorvastatin, a common drug that can lower blood cholesterol levels, was
Investigation Report on China Duloxetine Market, 2009-2018
Depression is a common mood disorder that belongs to high-incidence mental diseases worldwide. Its main clinical features are a state of low mood and aversion to activity, and sometimes even suicidal thoughts or behaviors. According to statistics from World Health Organization (WHO), depress
Investigation Report on China Budesonide Market, 2010-2019
With the climatic and environmental changes, seasonal asthma has become the main reason for respiratory ailments. According to an epidemiological survey, the incidence of respiratory ailments is 16% of the incidence of all diseases. About 280 million people in the world suffer from different d

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonchina.com
Fax Number: +91 22 27812707

Follow Us On: